Who is sponsoring NCT05731388?

NCT05731388 is sponsored by Unity Health Toronto.

What drugs are being tested in NCT05731388?

Interventions in NCT05731388: Push enteroscopy.

What condition does NCT05731388 study?

NCT05731388 studies Obscure Gastrointestinal Bleeding, Gastrointestinal Diseases, Gastrointestinal Bleed, Angiodysplasia Intestine.

Is NCT05731388 still recruiting?

NCT05731388 is currently status unknown. Last updated 2 June 2023.

Last reviewed 2023-06-02 · How we verify

NCT05731388

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Depth of Small Bowel Insertion at Push Enteroscopy by Using Capsule Endoscopy

Status unknown Last updated 2 June 2023

What this trial tests

trial testing Push enteroscopy in Obscure Gastrointestinal Bleeding in 59 participants. Status unknown.

Timeline

1 July 2019

Primary endpoint
1 November 2023

1 December 2023

Quick facts

Lead sponsor	Unity Health Toronto
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	59
Start date	1 July 2019
Primary completion	1 November 2023
Estimated completion	1 December 2023
Sites	1 location across Canada

Drugs / interventions tested

Push enteroscopy

Conditions studied

Obscure Gastrointestinal Bleeding — all drugs for Obscure Gastrointestinal Bleeding →
Gastrointestinal Diseases — all drugs for Gastrointestinal Diseases →
Gastrointestinal Bleed — all drugs for Gastrointestinal Bleed →
Angiodysplasia Intestine — all drugs for Angiodysplasia Intestine →

Sponsor

Unity Health Toronto — full company profile →

Who can join

18 and older, any sex, with Obscure Gastrointestinal Bleeding or Gastrointestinal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bleeding from the gastrointestinal tract can originate from the small bowel. Typically, upper and lower endoscopies are unable to identify the site of bleeding and patients need to undergo special endoscopies with longer cameras to examine the small bowel and find the bleeding site. One of the most commonly used scopes to investigate the first part of the small intestinal is called "push enteroscopy". This is an upper endoscopy that uses a pediatric colonoscope, which is longer. To date, it is unknown what percentage of small bowel can be observed with this technique. Hence, this study aimed to determine the extent of small bowel examined by push enteroscopy. Consecutive patients with suspected bleeding from the small intestine will undergo a push enteroscopy and the depth of the examination will be marked with metallic clips. Subsequently, patients will have a capsule endoscopy, which is a little camera that will take multiple pictures of the whole small intestine. The percentage of small bowel that the push enteroscopy examined will be determined by the percentage of small bowel corresponding to the location of the clips visualized on capsule endoscopy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obscure Gastrointestinal Bleeding

Currently open trials in the same condition.

NCT07089030 — Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy · NA · recruiting
NCT04646083 — Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon · recruiting

Other Unity Health Toronto trials

Trials by the same sponsor.

NCT07507409 — Innovative Sternal Closure Techniques: Evaluating STRATAFIX™ and DERMABOND™ for Reduced Complications in CABG Patients · Phase 4 · not yet recruiting
NCT07455487 — First Appendectomy Using Revolve Surgical Robotic Arm · NA · not yet recruiting
NCT07301632 — Ecstasy to Alleviate SEvere Chronic Neuropathic Pain Trial · Phase 2 · recruiting
NCT07314905 — Adaptive Platform Trial of Treatments for Respiratory Infections in Community Settings (TreatResp) · Phase 3 · not yet recruiting
NCT06571916 — Brief Skills for Safer Living (Brief-SfSL) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05731388 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Unity Health Toronto
Last refreshed: 2 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05731388.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing